Alzheimer's dementia, now regarded as a disease of senium as well as pre-senium, presents as an impairment of higher mental function' and is characterised histologically by large numbers of neuritic (senile) plaques and neurofibrillary tangles in the neocortex and hippocampus.2 A further characteristic is a substantial decline of presynaptic cholinergic function in the neocortex. 3 Although the involvement of other iueurotransmitter systems is not well established, evidence implicating both a cortical' 8 and a subcortical9-" dysfunction of monoamine neurotransmitter systems has emerged.
Indirect assessment of cerebral monoamine function in memory disorders by analysis of metabolites in cerebrospinal fluid (CSF) has identified a specific alteration in Korsakoffs psychosis.'2 Similar studies in Alzheimer's dementia have yielded conflicting results, with some authors reporting reduced concentrations of 5-hydroxyindoleacetic acid (5-HIAA)'3 and homovanillic acid (HVA)'3-'8 while others [19] [20] [21] find no change. It seems likely that these discrepancies are partly due to differences in diag-nostic criteria since the diagnosis of Alzheimer's dementia was not verified by neurohistological examination in any of these studies.
The present investigation compared the concentrations of 3-methoxy-4-hydroxyphenylglycol (MHPG), 5 but not Alzheimer (r = 0*09, n = 34) patients. Age did not correlate with either MHPG or 5-HIAA. Table 2 shows that in comparison with agematched control subjects, the HVA content in the CSF of presenile Alzheimer patients was reduced by 28% and that the 5-HIAA content of drug-free Alzheimer patients was reduced by 25%. MHPG was unchanged. 5-HIAA and MHPG were unaltered in senile Alzheimer patients. The elevation of HVA content with age in control subjects invalidates direct comparison between mean values for senile Alzheimer patients and the younger control subjects. Extrapolation from the figure, however, suggests that 50 ng/ml is an appropriate control value. This indicates that homovanillic acid in the CSF of Alzheimer patients of senile age is reduced by 42%. 
